Login

BioMed Builds on US Biotech Buying Strategy With New Purchase in Greater Boston

Assembly Square Project Aims To Support Region’s Growing Life Science Industry
BioMed Realty acquired a development site in Somerville, Massachusetts, ready for 1.3 million square feet of space for life science tenants. (BioMed)
BioMed Realty acquired a development site in Somerville, Massachusetts, ready for 1.3 million square feet of space for life science tenants. (BioMed)
CoStar News
January 19, 2021 | 9:21 P.M.

Blackstone Group’s newly recapitalized BioMed Realty is wasting no time expanding its life science office holdings in greater Boston, the U.S. biotech and pharmaceutical research real estate capital. The company’s first major acquisition of the year follows two similar purchases that closed out 2020.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE